Interleukin 24 in Epidermal Function
Interleukin 24 in Epidermal Function
批准号:
7229781
负责人:
PENG LIANG
金额:
$22.92万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-03-09 至 2008-12-31
关键词:
Animal ModelAnti-Inflammatory AgentsAnti-inflammatoryAreaB-LymphocytesBindingBiological ModelsBiological ProcessCell ProliferationCellsChronicComplexConditionCutaneousCytokine ActivationCytokine Network PathwayCytokine SignalingDefectDermalDrug or chemical Tissue DistributionEpidermisExcisionExhibitsFamilyGrowth FactorHematopoieticHumanInflammatory ResponseInjuryInterleukin-1Interleukin-10Interleukin-24Interleukin-3Knockout MiceLigandsModelingMononuclearMusNumbersPhysiologicalPlayProcessProductionRecruitment ActivityResearchResearch PersonnelRoleSignal PathwaySignal TransductionSiteSkinSourceTestingTissuesWound Healingattenuationcytokinekeratinocytemacrophagemembermigrationmonocyteparacrineprogramsreceptorreceptor expressionresponsewound
中文摘要
描述(由申请人提供):本次R21研究计划的总体目标是揭示我们最近发现的一种新的细胞因子IL-24的生理功能。IL-24属于IL-10细胞因子家族。我们已经鉴定出两个异二聚体EL-24受体(IL-22R1/IL-20R2和IL-20R1和IL-20R2),当它们与配体结合时导致STATs激活。IL-24受体表达的组织分布分析表明,表皮是IL-24的主要靶组织之一,而IL-10主要作用于造血细胞。我们发现角化细胞不仅表达IL-24受体,而且可以被IL-24激活,这主要导致StatS的激活。同样,stat 3基因敲除小鼠在伤口愈合方面表现出缺陷。此外,IL-24的表达在皮肤创面愈合过程中显著增加,并表明聚集在伤口表皮下的浸润性单核细胞是IL-24的来源。从逻辑上讲,我们选择伤口愈合过程作为模型系统来探索IL-24信号的生理功能。我们假设IL-24可能是至少三种角质形成细胞功能的重要调节因子。首先,浸润单核细胞产生的IL-24可能以类似于造血细胞上的IL-10的方式起作用,抑制表皮合成促炎细胞因子,如IL-1和TNF-a。在这方面,IL-24可能作为一种抗炎细胞因子,在伤口愈合过程中表明皮肤炎症反应的衰减或最终终止。其次,IL-24可能在组织修复过程中作为角质细胞增殖、迁移和分化的信号。我们发现IL-24可以以IL-24受体依赖的方式替代IL-3作为小鼠IL-3依赖性前b细胞的生存和生长因子,这一发现支持了这一假设。第三,IL-24可能是参与伤口愈合过程的更复杂的细胞因子网络的一部分。我们提出以下具体目的来验证这些假设:具体目的1:通过检测IL-24是否能抑制促炎细胞因子的产生,促进细胞增殖、迁移和分化,确定IL-24对角质形成细胞的生物学功能。特异性目的2:利用小鼠皮肤切除创面模型和IL-24拮抗剂,探讨IL-24在创面愈合中的作用。
英文摘要
DESCRIPTION (provided by applicant): The overall objective of this R21 research plan is to uncover the physiological functions of IL-24, a new cytokine that we recently discovered. IL-24 belongs to the IL-10 family of cytokines. We have identified two heterodimeric EL-24 receptors (IL-22R1/IL-20R2 and IL-20R1 and IL-20R2) which when bound to the ligand leads to STATs activation. Tissue distribution analysis of IL-24 receptor expression indicates that epidermis is one of the major IL-24 target tissues, in contrast to IL-10, which acts mainly on cells from hemopoeitic lineage. We showed that keratinocyres not only expresses IL-24 receptors but also can be activated by IL-24, which leads to mainly StatS activation. Consistently, stat 3 knockout mice were shown to exhibit defects in wound healing. Furthermore, IL-24 expression was found greatly increased during cutaneous wound healing process, and infiltrating mononuclear cells congregating right beneath the wounded epidermis were shown to be the source of IL-24 production. Logically, here we have selected the wound healing process as a model system to explore the physiological functions of IL-24 signaling. We hypothesize that IL-24 may be an important regulator for at least three keratinocyte functions. First, IL-24 produced by infiltrating monocytes may function, in an analogous manner to IL-10 on hematopoietic cells, to inhibit the synthesis of proinflammatory cytokines such as IL-1 and TNF-a by epidermis. In this regard, IL-24 may function as an anti-inflammatory cytokine that signals the attenuation or ultimate termination of inflammatory responses in the skin during the wound healing process. Secondly, IL-24 may function as a signal for keratinocyte proliferation, migration and differentiation during tissue repair. This hypothesis is supported by our finding that IL-24 could substitute IL-3 as a survival and growth factor for murine IL-3 dependent pro-B cells in IL-24 receptor-dependent manner. Thirdly, IL-24 may be part of a more complex cytokine network involved in the wound healing process. We propose the following specific aims to test these hypothesis: Specific Aim 1: To determine the biological functions of IL-24 on keratinocytes by testing if IL-24 can inhibit the production of proinflammatory cytokines, and promote cell proliferation, migration and differentiation. Specific Aim 2: To determine the role of IL-24 in wound healing using mouse skin excision wound model and IL-24 antagonists.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Trimer-Tag: A Technology for Producing Trivalent Biologics
-
批准号:8200347
-
项目类别:
-
资助金额:$22.47万
-
财政年份:2011
-
负责人:PENG LIANG
-
依托单位:
Interleukin 24 in Epidermal Function
-
批准号:7027249
-
项目类别:
-
资助金额:$15.27万
-
财政年份:2006
-
负责人:PENG LIANG
-
依托单位:
p53 target Genes in Apoptosis
-
批准号:6861741
-
项目类别:
-
资助金额:$27.86万
-
财政年份:2004
-
负责人:PENG LIANG
-
依托单位:
p53 target Genes in Apoptosis
-
批准号:7191580
-
项目类别:
-
资助金额:$26.42万
-
财政年份:2004
-
负责人:PENG LIANG
-
依托单位:
p53 target Genes in Apoptosis
-
批准号:7025082
-
项目类别:
-
资助金额:$27.2万
-
财政年份:2004
-
负责人:PENG LIANG
-
依托单位:
p53 target Genes in Apoptosis
-
批准号:6718332
-
项目类别:
-
资助金额:$27.86万
-
财政年份:2004
-
负责人:PENG LIANG
-
依托单位:
STREAMLINING DIFFERENTIAL DISPLAY TECHNOLOGY
-
批准号:2689867
-
项目类别:
-
资助金额:$24.45万
-
财政年份:1998
-
负责人:PENG LIANG
-
依托单位:
STREAMLINING DIFFERENTIAL DISPLAY TECHNOLOGY
-
批准号:2896332
-
项目类别:
-
资助金额:$24.27万
-
财政年份:1998
-
负责人:PENG LIANG
-
依托单位:
STREAMLINING DIFFERENTIAL DISPLAY TECHNOLOGY
-
批准号:6173245
-
项目类别:
-
资助金额:$24.99万
-
财政年份:1998
-
负责人:PENG LIANG
-
依托单位:
STREAMLINING DIFFERENTIAL DISPLAY TECHNOLOGY
-
批准号:6376631
-
项目类别:
-
资助金额:$25.74万
-
财政年份:1998
-
负责人:PENG LIANG
-
依托单位:
MOB-5 IN COLORECTAL & PANCREATIC CANCER
-
批准号:2465338
-
项目类别:
-
资助金额:$20.27万
-
财政年份:1997
-
负责人:PENG LIANG
-
依托单位:
MOB-5 IN COLORECTAL & PANCREATIC CANCER
-
批准号:6328975
-
项目类别:
-
资助金额:$20.77万
-
财政年份:1997
-
负责人:PENG LIANG
-
依托单位:
MOB-5 IN COLORECTAL & PANCREATIC CANCER
-
批准号:6124548
-
项目类别:
-
资助金额:$20.16万
-
财政年份:1997
-
负责人:PENG LIANG
-
依托单位:
MOB-5 IN COLORECTAL & PANCREATIC CANCER
-
批准号:2837736
-
项目类别:
-
资助金额:$19.58万
-
财政年份:1997
-
负责人:PENG LIANG
-
依托单位:
DISPLAY OF MRNAS FROM NORMAL TUMORIGENIC CELLS
-
批准号:2104307
-
项目类别:
-
资助金额:$8.1万
-
财政年份:1994
-
负责人:PENG LIANG
-
依托单位:
海外基金